Kyoto, Japan

Kazuhiro Kobuke

This inventor holds 4 USPTO granted patents. Top assignee: Ono Pharmaceutical Co., Ltd.. Active years: 2005-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhiro Kobuke. Retrieved from https://idiyas.com/inventor/kazuhiro-kobuke

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2005-2011

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Kazuhiro Kobuke: Innovator in Cardiovascular Research

Introduction

Kazuhiro Kobuke is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of cardiovascular research, particularly in understanding the mechanisms of vascular smooth muscle in relation to various medical conditions.

Latest Patents

Kobuke holds 4 patents, with his latest inventions focusing on a polypeptide known as ESDN. This polypeptide plays a crucial role in addressing morbid vascular smooth muscle issues related to restenosis after percutaneous transluminal coronary angioplasty (PTCA) and arterial sclerosis. His work on polynucleotides encoding the polypeptide further emphasizes its utility in the cardiovascular system.

Career Highlights

Kazuhiro Kobuke is associated with Ono Pharmaceutical Co., Ltd., where he continues to advance his research and innovations. His work has been instrumental in developing therapeutic strategies for cardiovascular diseases.

Collaborations

Kobuke has collaborated with notable colleagues, including Tasuku Honjo and Kei Tashiro, enhancing the impact of his research through shared expertise and insights.

Conclusion

Kazuhiro Kobuke's contributions to cardiovascular research through his innovative patents and collaborations highlight his role as a key figure in the field. His work continues to pave the way for advancements in medical treatments related to vascular health.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…